MedTrace Logo

A Study the Population Pharmacokinetics of Children of Infectious Disease in Central Nervous System

NCT03960905 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2019-05-23

No results posted yet for this study

Summary

The investigators aim to study the population pharmacokinetics of children receiving the anti-infective drugs for treatment of infectious disease in central nervous system.

Conditions

  • Central Nervous System Infection

Interventions

OTHER

Children with the usage of anti-infective drugs

According to the models of population pharmacokinetics,the investigators and want to correlate use of antibiotics with treatment effectiveness and safety in children.

Sponsors & Collaborators

  • Beijing Children's Hospital

    collaborator OTHER

  • Wei Zhao

    lead OTHER

Eligibility

Min Age
29 Days
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03960905 on ClinicalTrials.gov